What to Expect at Your First Telehealth Appointment for Wegovy

Your first telehealth appointment for Wegovy typically lasts 20–45 minutes. The clinician will review your medical history, current medications, and weight-related health conditions to determine whether semaglutide 2.4 mg meets FDA eligibility criteria for you. You won't need labs drawn beforehand in most cases, but being prepared makes the visit faster and more productive.

Who Qualifies for Wegovy According to FDA Labeling?

Before your appointment, it helps to know the clinical thresholds the prescriber is checking against. According to the FDA-approved prescribing information for Wegovy, the medication is indicated for adults who meet at least one of these criteria:

• A body mass index (BMI) of 30 or higher (classified as obesity)
• A BMI of 27 or higher combined with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol

Wegovy is also FDA-approved for adolescents aged 12 and older meeting similar BMI thresholds, though telehealth rules for minors vary by state. The prescriber will also screen for contraindications, including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), as Wegovy carries an FDA boxed warning for these conditions.

What Should You Prepare Before the Visit?

Arriving organized saves time and helps the clinician make a well-informed decision. Gather the following before your appointment:

• Current medication list — include doses and frequency, especially insulin or oral diabetes drugs, as semaglutide can affect blood sugar.
• Recent lab results — not always required, but blood glucose (HbA1c), lipid panel, or thyroid values are useful if you have them.
• Your weight history — approximate highest and lowest adult weights, and what diets or programs you have already tried.
• Insurance or payment information — Wegovy's list price exceeds $1,300 per month; knowing your coverage in advance avoids surprises.
• A quiet, private space with a reliable internet connection and a camera-enabled device.
• A home scale reading taken the morning of the visit, ideally without shoes.

What Questions Will the Prescriber Ask?

Telehealth clinicians follow the same clinical assessment as an in-person obesity medicine visit. Expect questions in these categories:

• Weight and metabolic history: How long have you carried excess weight? Do you have prediabetes, type 2 diabetes, hypertension, or sleep apnea?
• GI history: Have you had pancreatitis, gallbladder disease, or severe gastroparesis? These may be contraindications or reasons for closer monitoring.
• Mental health: Some platforms screen for active suicidal ideation or eating disorders such as purging-type bulimia, which require additional clinical judgment before prescribing.
• Family history: Thyroid cancer (specifically medullary type) or MEN 2 in a first-degree relative is a hard contraindication per FDA labeling.
• Goals and expectations: The clinician may ask about your weight-loss goals to ensure expectations align with clinical evidence. The STEP 1 trial published in the New England Journal of Medicine (Wilding et al., 2021) found a mean body weight reduction of approximately 14.9% over 68 weeks — a figure often used to set realistic expectations.

What Does the Dose Schedule Look Like After You Are Prescribed?

If the clinician determines you are a candidate, Wegovy is started at a low dose and escalated gradually over 16 weeks to minimize nausea and gastrointestinal side effects. The table below reflects the standard titration schedule from the FDA prescribing information.

What Happens After the Appointment?

If you are prescribed Wegovy, here is the typical post-visit flow through most telehealth platforms:

1. E-prescription sent — usually within a few hours to your chosen pharmacy or a mail-order specialty pharmacy.
2. Prior authorization — many insurers require this before filling; your platform or pharmacy team typically handles the paperwork, but it can take days to weeks.
3. Injection training — the pen is pre-filled and single-use; most platforms provide a short video or written guide. The FDA patient information leaflet also includes step-by-step instructions.
4. Follow-up scheduling — most telehealth providers schedule a check-in at 4–8 weeks to review tolerability, side effects, and whether dose escalation should proceed on schedule.
5. Ongoing monitoring — heart rate elevation is a known side effect noted in FDA labeling; report a sustained resting heart rate increase of more than 15 bpm to your prescriber.

Frequently Asked Questions

Your telehealth appointment is the foundation of your Wegovy journey, and going in prepared makes a real difference. If you want to understand how Wegovy compares to other GLP-1 medications available through telehealth, see our article on Ozempic vs. Wegovy: What Is the Difference? for a side-by-side breakdown of the two semaglutide products. Every person's health profile is unique, and only a licensed prescriber who has reviewed your full medical history can determine whether Wegovy is right for you — so bring every question you have to that first visit.